These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2013328)

  • 1. Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro.
    Murata M; Miyashita S; Yokoo C; Tamai M; Hanada K; Hatayama K; Towatari T; Nikawa T; Katunuma N
    FEBS Lett; 1991 Mar; 280(2):307-10. PubMed ID: 2013328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo.
    Towatari T; Nikawa T; Murata M; Yokoo C; Tamai M; Hanada K; Katunuma N
    FEBS Lett; 1991 Mar; 280(2):311-5. PubMed ID: 2013329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA074 methyl ester: a proinhibitor for intracellular cathepsin B.
    Buttle DJ; Murata M; Knight CG; Barrett AJ
    Arch Biochem Biophys; 1992 Dec; 299(2):377-80. PubMed ID: 1444478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors.
    Tsuchiya K; Kohda Y; Yoshida M; Zhao L; Ueno T; Yamashita J; Yoshioka T; Kominami E; Yamashima T
    Exp Neurol; 1999 Feb; 155(2):187-94. PubMed ID: 10072294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.
    Barrett AJ; Kembhavi AA; Brown MA; Kirschke H; Knight CG; Tamai M; Hanada K
    Biochem J; 1982 Jan; 201(1):189-98. PubMed ID: 7044372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective inhibition of cathepsin B and general inhibition of cysteine proteinases on lysosomal proteolysis in rat liver in vivo and in vitro.
    Ohshita T; Nikawa T; Towatari T; Katunuma N
    Eur J Biochem; 1992 Oct; 209(1):223-31. PubMed ID: 1382984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat liver thiol proteinases: cathepsin B, cathepsin H and cathepsin L.
    Katunuma N; Towatari T; Kominami E; Hashida S; Takio K; Titani K
    Acta Biol Med Ger; 1981; 40(10-11):1419-25. PubMed ID: 6177136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-64 [L-trans-epoxysuccinyl-leucyl-amido(4-guanidino)butane] and related epoxides as inhibitors of cysteine proteinases.
    Barrett AJ; Kembhavi AA; Hanada K
    Acta Biol Med Ger; 1981; 40(10-11):1513-7. PubMed ID: 7044005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular design of potent inhibitor specific for cathepsin B based on the tertiary structure prediction.
    Sumiya S; Yoneda T; Kitamura K; Murata M; Yokoo C; Tamai M; Yamamoto A; Inoue M; Ishida T
    Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):299-303. PubMed ID: 1606628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.
    Crawford C; Mason RW; Wikstrom P; Shaw E
    Biochem J; 1988 Aug; 253(3):751-8. PubMed ID: 2845932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells.
    Montaser M; Lalmanach G; Mach L
    Biol Chem; 2002; 383(7-8):1305-8. PubMed ID: 12437121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine cathepsins are not critical for TRAIL- and CD95-induced apoptosis in several human cancer cell lines.
    Špes A; Sobotic B; Turk V; Turk B
    Biol Chem; 2012 Dec; 393(12):1417-31. PubMed ID: 23667901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases.
    Martichonok V; Plouffe C; Storer AC; Ménard R; Jones JB
    J Med Chem; 1995 Aug; 38(16):3078-85. PubMed ID: 7636871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of serum albumin by rat liver and kidney lysosomes.
    Ohshita T; Hiroi Y
    J Nutr Sci Vitaminol (Tokyo); 1998 Oct; 44(5):641-53. PubMed ID: 9919484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsins B and L in synovial fluids from patients with rheumatoid arthritis and the effect of cathepsin B on the activation of pro-urokinase.
    Ikeda Y; Ikata T; Mishiro T; Nakano S; Ikebe M; Yasuoka S
    J Med Invest; 2000 Feb; 47(1-2):61-75. PubMed ID: 10740981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epoxysuccinyl dipeptides as selective inhibitors of cathepsin B.
    Gour-Salin BJ; Lachance P; Plouffe C; Storer AC; Ménard R
    J Med Chem; 1993 Mar; 36(6):720-5. PubMed ID: 8459399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labelling of cysteine proteinases in purified lysosomes.
    Wilcox D; Mason RW
    Biochem Soc Trans; 1989 Dec; 17(6):1080-1. PubMed ID: 2628091
    [No Abstract]   [Full Text] [Related]  

  • 18. WF14865A and B, new cathepsins B and L inhibitors produced by Aphanoascus fulvescens. I. Taxonomy, production, purification and biological properties.
    Otsuka T; Muramatsu Y; Nakanishi T; Hatanaka H; Okamoto M; Hino M; Hashimoto S
    J Antibiot (Tokyo); 2000 May; 53(5):449-58. PubMed ID: 10908107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors.
    Schaschke N; Assfalg-Machleidt I; Machleidt W; Moroder L
    FEBS Lett; 1998 Jan; 421(1):80-2. PubMed ID: 9462845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64.
    Tamai M; Matsumoto K; Omura S; Koyama I; Ozawa Y; Hanada K
    J Pharmacobiodyn; 1986 Aug; 9(8):672-7. PubMed ID: 3023601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.